Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

312.00p
   
  • Change Today:
    -16.50p
  • 52 Week High: 445.00p
  • 52 Week Low: 232.50p
  • Currency: UK Pounds
  • Shares Issued: 106.00m
  • Volume: 92,786
  • Market Cap: £330.72m
  • RiskGrade: 125

OXB Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.
Registrars: Capita Registrars

Key Personnel

CEO: Frank Mathias
CFO: Lucinda (Lucy) Crabtree
Chairman: Roch Doliveux
Independent Non-Executive Director: Heather Preston
Independent Non-Executive Director: Namrata P Patel
Senior Independent Director: Dame Kay Davies
Vice Chairman: Stuart Henderson
Non-Executive Dir: Laurence Espinasse, Colin Bond , Peter Soelkner, Robert Ghenchev

Contact Details

Address: Windrush Court, Transport Way, Oxford, United Kingdom, OX4 6LT
Phone: +44 (0) 1865 783 000
Fax: +44 (0) 1865 783 001
Website: http://www.oxb.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: techMARK, FTSE Small Cap, FTSE All-Share, FTSE techMARK Focus
Overseas Listings: BATSLON:OXBL
ISIN: GB00BDFBVT43

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 312.00p
Change Today -16.50p
% Change -5.02 %
52 Week High 445.00p
52 Week Low 232.50p
Volume 92,786
Shares Issued 106.00m
Market Cap £330.72m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.98% below the market average29.98% below the market average29.98% below the market average29.98% below the market average29.98% below the market average
19.15% above the sector average19.15% above the sector average19.15% above the sector average19.15% above the sector average19.15% above the sector average
Price Trend
44.54% below the market average44.54% below the market average44.54% below the market average44.54% below the market average44.54% below the market average
14.89% above the sector average14.89% above the sector average14.89% above the sector average14.89% above the sector average14.89% above the sector average
Income Not Available
Growth
1.88% above the market average1.88% above the market average1.88% above the market average1.88% above the market average1.88% above the market average
3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 28-May-2025

Time Volume / Share Price
16:35 19,023 @ 312.00p
16:35 133 @ 312.00p
16:35 68 @ 312.00p
16:35 31 @ 312.00p
16:35 420 @ 312.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page